Pharmaceutical preparation for prevention and/or treatment for cataract
US5698585A · kind A · utility
5Cited by
0References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 12, 1996 |
| Grant date | Dec 16, 1997 |
| Priority date | — |
| Expiry date | Apr 12, 2016 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/341
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
In order to prevent or treat cataract, present invention features 3(2H)-furanone derivatives having 3(2H)-furanone skeleton as a main structure and/or pharmaceutically acceptable salts thereof, pharmaceutical preparations containing the derivatives and/or the salts thereof, treatment methods of cataract, and their use. The 3(2H)-furanone derivatives have excellent effects for the prevention and/or treatment of cataract, for instance, senile cataract caused by oxidation disorder. Particularly, the pharmaceutical preparations have good effect for the prevention and/or treatment of cataract when they are administrated as ophtalmics.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.